BMEA - Bathi sadurunge bunga, pajak, lan amortisasi Biomea Fusion Inc
Biomea Fusion, Inc. (BMEA) is developing endocrinology drugs through partnerships with clinics. Actual operating profit confirms this stage, and the parameter has stabilized at 0.00. The company's innovations focus on pancreatic cell regeneration for complete healing. However, FDA regulatory complexities and significant research costs create risks of shareholder equity dilution.
Ringkesan rincian data analitis Biomea Fusion (BMEA)
- kuotasi saiki lan rata-rata prakiraan nilai:
- statistik kapitalisasi pasar:
- data kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Biomea Fusion, Inc.|BMEA - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Biomea Fusion Inc|BMEA - Utang perusahaan|Rasio utang marang kapitalisasi buku Biomea Fusion|BMEA - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Biomea Fusion|Koefisien jangkoan perantara biomeafusion.com
- rincian asil keuangan lan kelipatan valuasi:
BMEA - Bathi resik perusahaan|Bathi mangsa ngarep Biomea Fusion, Inc.|BMEA - Pangali P/E|Rega marang bathi mangsa ngarep biomeafusion.com|BMEA - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Biomea Fusion|BMEA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Biomea Fusion|BMEA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan biomeafusion.com|BMEA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Biomea Fusion, Inc.
Analisis kabeh metrik perusahaan:Biomea Fusion Corp (BMEA)
The effective utilization of small molecule synthesis laboratories for diabetes determines the actual scale of operations for Biomea Fusion, Inc. (BMEA). This operating income before taxes and depreciation measures the net cash flow from core activities, excluding accounting revaluations and one-time adjustments. By analyzing this chart, an investor separates the fundamental stability of the business from temporary anomalies, assessing actual profitability without the influence of non-cash write-offs.
Karo sapa Biomea Fusion, Inc. saingan
ASND - Bathi operasional sadurunge ngurangi amortisasi|Madrigal Pharmaceuticals - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|AKRO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MTSR (Metsera Corp) - Bathi operasional EBITDA|Bathi operasional EBITDA MoonLake Corp|Bathi operasional EBITDA CRNX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAMS (newamsterdampharma.com)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Soleno Therapeutics, Inc. SLNO|Amicus Therapeutics Inc (FOLD) - Bathi sadurunge bunga, pajak, lan amortisasi|ETNB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|AGIO: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|GPCR: Bathi operasional EBITDA|MDXG - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Rezolute|Lexicon Pharmaceuticals Inc (LXRX) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi MBX Bio (MBX)|Bathi operasional sadurunge ngurangi amortisasi Altimmune Pharma ALT|Bathi operasional EBITDA AARD (Aardvark Therapeutics Inc)|sagimet.com - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|BioAge - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Quince Therapeutics QNCX|Fractyl (GUTS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi vTv Therapeutics (VTVT)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Agape ATP Corp|Bathi operasional sadurunge ngurangi amortisasi Pluri Inc (PLUR)|Bathi operasional EBITDA SYBX|LPCN - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA MTNB (Matinas BioPharma Holdings)|Bathi operasional EBITDA sprucebiosciences.com SPRB|GLTO: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CTCX (carmellrx.com)|LUMO: Bathi operasional EBITDA|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi ONVO (Organovo Holdings)|Bathi operasional sadurunge ngurangi amortisasi RDUS
